Cargando…

PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks

To compare the effectiveness and safety of transjugular intrahepatic portosystemic shunt (TIPS) with endoscopic therapy plus non-selective β-blockers (NSBBs) for secondary prevention of gasroesophageal variceal bleeding (GEVB) in cirrhotic patients with high-risk factors of treatment failure. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yongjie, Zhang, Wen, Zhang, Zihan, Luo, Jianjun, Gu, Junying, Liu, Qingxin, Ma, Jingqin, Yan, Zhiping, Chen, Shiyao, Wang, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams And Wilkins 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423526/ https://www.ncbi.nlm.nih.gov/pubmed/32744824 http://dx.doi.org/10.1097/MEG.0000000000001686

Ejemplares similares

Number of endoscopic sessions to eradicate varices identifies high risk of rebleeding in cirrhotic patients
por: Guo, Huiwen, et al.
Publicado: (2022)

CT-Based Radiomics Score Can Accurately Predict Esophageal Variceal Rebleeding in Cirrhotic Patients
por: Meng, Dongxiao, et al.
Publicado: (2021)

Transjugular intrahepatic portosystemic shunt for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: study protocol for a randomised controlled trial
por: Qi, Xingshun, et al.
Publicado: (2013)

Aluminum phosphate gel reduces early rebleeding in cirrhotic patients with gastric variceal bleeding treated with histoacryl injection therapy
por: Zeng, Hao-Tian, et al.
Publicado: (2023)

Transjugular intrahepatic portosystemic shunt may be superior to conservative therapy for variceal rebleeding in cirrhotic patients with non-tumoral portal vein thrombosis: A hypothesis
por: Qi, Xingshun, et al.
Publicado: (2012)

Effect of Alcohol Consumption on Variceal Rebleeding and Mortality
por: Henderson, J. Michael
Publicado: (1992)

Long-term Outcomes of Endoscopic Variceal Ligation to Prevent Rebleeding in Children with Esophageal Varices
por: Kang, Ki Soo, et al.
Publicado: (2013)

Emergency endoscopic variceal ligation in cirrhotic patients with blood clots in the stomach but no active bleeding or stigmata increases the risk of rebleeding
por: Kim, Su Jin, et al.
Publicado: (2016)

Clinical algorithms for the prevention of variceal bleeding and rebleeding in patients with liver cirrhosis
por: Pfisterer, Nikolaus, et al.
Publicado: (2021)

Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial
por: Agarwal, Ajit, et al.
Publicado: (2015)

Carvedilol versus propranolol in the prevention of variceal rebleeding in hepatosplenic schistosomiasis: Efficacy and safety
por: Razafindrazoto, Chantelli Iamblaudiot, et al.
Publicado: (2022)

Measurement of Exhaled Nitric Oxide in Cirrhotic Patients with Esophageal and Gastric Varices
por: Huang, Xiaoquan, et al.
Publicado: (2019)

Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction
por: Zhou, Yongjie, et al.
Publicado: (2023)

Mortality and rebleeding following variceal haemorrhage in liver cirrhosis and periportal fibrosis
por: Mohammed, Sara Elfadil Abbas, et al.
Publicado: (2016)

Effect of aluminum phosphate gel on prevention of early rebleeding after ligation of esophageal variceal hemorrhage
por: Zhang, Zhu-Liang, et al.
Publicado: (2021)

Variceal bleeding in cirrhotic patients
por: Mallet, Maxime, et al.
Publicado: (2017)

Transjugular Intrahepatic Portosystemic Shunt With or Without Gastroesophageal Variceal Embolization for the Prevention of Variceal Rebleeding: A Systematic Review and Meta-Analysis
por: Jaber, Fouad, et al.
Publicado: (2023)

Development of a Costimulatory Molecule Signature to Predict Prognosis, Immune Landscape, and Response to Immune Therapy for Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: A systematic review and meta-analysis of randomized controlled trials
por: Qi, Xingshun, et al.
Publicado: (2016)

The influence of shunting left/right portal vein branch on post-TIPS hepatic encephalopathy: a study protocol for multicenter randomized blinded controlled trial
por: Ma, Jingqin, et al.
Publicado: (2023)

The Effect of Puncture Sites of Portal Vein in TIPS with ePTFE-Covered Stents on Postoperative Long-Term Clinical Efficacy
por: Chen, Si-liang, et al.
Publicado: (2019)

Associations Between Endoscopic Primary Prophylaxis and Rebleeding in Liver Cirrhosis Patients with Esophagogastric Variceal Bleeding
por: Gao, Yanying, et al.
Publicado: (2022)

A Liver Stiffness Measurement-Based Nomogram Predicts Variceal Rebleeding in Hepatitis B-Related Cirrhosis
por: Liu, Linxiang, et al.
Publicado: (2022)

Individualized portal pressure gradient threshold based on liver function categories in preventing rebleeding after TIPS
por: Xia, Yifu, et al.
Publicado: (2023)

The Impact of Socioeconomic Status on Staging, Prognosis in Hepatocellular Carcinoma
por: Zhou, Yongjie, et al.
Publicado: (2022)

Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
por: Zhang, Qun, et al.
Publicado: (2020)

Comparative study for predictability of type 1 gastric variceal rebleeding after endoscopic variceal ligation: High-frequency intraluminal ultrasound study
por: Kim, Jeong Hwan, et al.
Publicado: (2021)

Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?
por: Kim, Ka Rham, et al.
Publicado: (2015)

Predictors of Rebleeding in Non-variceal Upper Gastrointestinal Bleeding of Peptic Ulcer Etiology in Kashmiri Population
por: Parveen, Shaheena, et al.
Publicado: (2023)

Albumin‑bilirubin grade and INR for the prediction of esophagogastric variceal rebleeding after endoscopic treatment in cirrhosis
por: Li, Fenghui, et al.
Publicado: (2023)

A Practical Model for Predicting Esophageal Variceal Rebleeding in Patients with Hepatitis B-Associated Cirrhosis
por: Liu, Linxiang, et al.
Publicado: (2023)

Risk of rebleeding from gastroesophageal varices after initial treatment with cyanoacrylate; a systematic review and pooled analysis
por: Hu, Zixuan, et al.
Publicado: (2020)

Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial
por: Wang, Lei, et al.
Publicado: (2016)

Hepatic venous pressure gradient and rebleeding risk of patients with nonalcoholic steatohepatitis cirrhosis after variceal bleeding
por: Shi, Yiqi, et al.
Publicado: (2023)

Development of a Novel Endovascular Brachytherapy Stent: A Proof-of-concept Study
por: Du, Nan, et al.
Publicado: (2021)

UK guidelines on the management of variceal haemorrhage in cirrhotic patients
por: Tripathi, Dhiraj, et al.
Publicado: (2015)

Pediatric Cirrhotic Variceal Bleed Precipitating Diabetic Ketoacidosis
por: Bridwell, Rachel E, et al.
Publicado: (2020)

Validation of the EVendo score for the prediction of varices in cirrhotic patients
por: Alswat, Khalid, et al.
Publicado: (2022)

Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study
por: Yang, Shih-Cheng, et al.
Publicado: (2017)

Prophylactic transcatheter arterial embolization reduces rebleeding in non-variceal upper gastrointestinal bleeding: A meta-analysis
por: Boros, Eszter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e7huv3kqlla5e8n339so1rsg6d